Suppression of Human Immunodeficiency Virus Type-1 Production by Coexpression of Catalytic-Region-Deleted N-Myristoyltransferase Mutants
スポンサーリンク
概要
- 論文の詳細を見る
N-Myristoyltransferase (NMT) isozymes, i.e., NMT1 and NMT2, are essential host factors for the AIDS-causing human immunodeficiency virus type-1 (HIV-1), by which the viral proteins Pr55gag and Nef are N-myristoylated. N-Myristoylation is important for the membrane targeting of modified proteins. Since it is predicted that approximately 0.5% of all proteins in the human genome are N-myristoylated, selective inhibition of closely HIV-1-associated NMT isozymes is thought to be important for the improvement of specificity in the anti-HIV-1 strategy with the inhibition of NMT function. NMT isozymes contain two characteristic structures, the N-terminal region and the catalytic region. Here, it was shown that the N-terminal region of each NMT isozyme is required for isozyme-specific binding to the ribosome. The specific binding of each isozyme to the ribosome was associated with HIV-1 production, in which NMT1 and NMT2 in the ribosome were suggested to be mainly related to Pr55gag and Nef, respectively. These results indicate that the N-terminal region that mediates binding to the ribosome can become a target for NMT-isozyme-specific inhibition, which could block HIV-1 production.
著者
-
MISUMI Shogo
Department of Pharmaceutical Biochemistry, Faculty of Medical and Pharmaceutical Sciences, Kumamoto
-
TAKAMUNE Nobutoki
Department of Pharmaceutical Biochemistry, Faculty of Medical and Pharmaceutical Sciences, Kumamoto
-
SHOJI Shozo
Department of Pharmaceutical Biochemistry, Faculty of Medical and Pharmaceutical Sciences, Kumamoto
-
Takamune Nobutoki
Dep. Of Pharmaceutical Biochemistry Fac. Of Medical And Pharmaceutical Sciences Kumamoto Univ.
-
Kuroe Tetsuya
Department of Pharmaceutical Biochemistry, Faculty of Life Sciences, Kumamoto University
-
Tanada Noriaki
Department of Pharmaceutical Biochemistry, Faculty of Life Sciences, Kumamoto University
-
Shoji Shozo
Department of Pharmaceutical Biochemistry, Faculty of Life Sciences, Kumamoto University
-
Misumi Shogo
Department of Pharmaceutical Biochemistry, Faculty of Life Sciences, Kumamoto University
関連論文
- Treatment of Breast Cancer Cells with Proteasome Inhibitor Lactacystin Increases the Level of Sensitivity to Cell Death Induced by Human Immunodeficiency Virus Type 1
- Suppression of Multiclade R5 and X4 Human Immunodeficiency Virus Type-1 Infections by a Coreceptor-Based Anti-HIV Strategy
- Novel Vaccine Strategy against AIDS Using Cyclic Dodecapeptide Mimicking the Loop Structure of HIV-1 Coreceptor, CCR5
- Blocking of Human Immunodeficiency Virus Type-1 Virion Autolysis by Autologous p2^ Peptide
- Suppression of Human Immunodeficiency Virus Type-1 Production by Coexpression of Catalytic-Region-Deleted N-Myristoyltransferase Mutants
- Blocking of Human Immunodeficiency Virus Type-1 Virion Autolysis by Autologous p2gag Peptide